Astellas Announces Five-Year Corporate Strategic Plan to Deliver Greater VALUE Faster for Patients and Position Itself as a Sustainable Growth Company
Go back to Astellas Announces Five-Year Corporate Strategic Plan to Deliver Greater VALUE Faster for Patients and Position Itself as a Sustainable Growth Company| Astellas Pharma Inc Unsponsored ADR (AMEX: ALPMY) | Delayed: 13.52 +0.07 (0.52%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $13.45 | 52 Week High | $19.40 | |||
| Open | $13.48 | 52 Week Low | $12.50 | |||
| Day High | $13.56 | P/E | N/A | |||
| Day Low | $13.45 | EPS | $0.00 | |||
| Volume | 56,748 | |||||
